Delivery Order SPE2DB22D3011-SPE2DB25FP7VV

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,463.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 24, 2025. The contract covers the procurement of DIGIFAB 40 MG VIALS, a pharmaceutical product, to support federal healthcare programs, particularly within military and veterans'...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,594.40, is a Firm Fixed Price Delivery Order for DIGIFAB 40 MG VIALS. The contract has an ultimate completion date of January 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,291.96 firm fixed-price delivery order contract is for the supply of DIGIFAB 40 MG VIALS medical products. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, SPE2DB22D3009|SPE2DB25FAP25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $23,860.38, is for the delivery of DIGIFAB 40 MG VIALS and has a completion date of January 22, 2025. The contract is a Firm Fixed Price Delivery Order and was awarded on January 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award, valued at $14,737.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDZPJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,475.50 firm-fixed-price delivery order is for the supply of DIGIFAB 40 MG VIALS, a medical product, with a completion date of March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award SPE2DB22D3009|SPE2DB24FAS39, with a ceiling value of $17,497.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Digifab 40 mg vials, a pharmaceutical product, and is a firm fixed price delivery order contract with a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,635.27, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of DIGIFAB 40 MG VIALS medical product to support military healthcare...
This federal contract award, SPE2DB22D2007|SPE2DB24FJ3XE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CROFAB VIALS, a pharmaceutical product, with a ceiling value of $23,662.59 and a completion date of July 3, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of pharmaceutical and medical supplies to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $11,865.70, is a Firm Fixed Price Delivery Order with a completion date of May 14, 2024. The products being delivered include a vial with diluent, identified by the item number 4564788154 !...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP7VV
    Delivery Order

This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP7VV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product, with a ceiling value of $3,280.14 and a completion date of November 27, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award is not designated as a set-aside and is part of the company's broader federal contracting portfolio with the DLA and other agencies.

Generated 5/20/25, 1:57 PM